Endpoints News 24. Nov. 2025 Novo Nordisk's semaglutide misses in closely-watched Alzheimer’s trials #Novo Nordisk #closely-watched Alzheimer
BioPharma Dive 24. Nov. 2025 Novo Nordisk’s GLP-1 misses goal in closely watched Alzheimer’s studies #Novo Nordisk #watched Alzheimer